EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Systems Biology for Drug Target Discovery in Acute Myeloid Leukemia

Svetlana Novikova iD, Tatiana Tolstova iD, Leonid Kurbatov iD, Tatiana Farafonova iD, Olga Tikhonova, Natalia Soloveva iD, Alexander Rusanov, Victor Zgoda iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25094618 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Svetlana Novikova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Chemistry, Pogodinskaya 10, 119121 Moscow, Russia. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Tretinoin, Systems Biology. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Combining new therapeutics with all-trans-retinoic acid (ATRA) could improve the efficiency of acute myeloid leukemia (AML) treatment. Modeling the process of ATRA-induced differentiation based on the transcriptomic profile of leukemic cells resulted in the identification of key targets that can be used to increase the therapeutic effect of ATRA. The genome-scale transcriptome analysis revealed the early molecular response to the ATRA treatment of HL-60 cells. In this study, we performed the transcriptomic profiling of HL-60, NB4, and K562 cells exposed to ATRA for 3–72 h. After treatment with ATRA for 3, 12, 24, and 72 h, we found 222, 391, 359, and 1032 differentially expressed genes (DEGs) in HL-60 cells, as well as 641, 1037, 1011, and 1499 DEGs in NB4 cells. We also found 538 and 119 DEGs in K562 cells treated with ATRA for 24 h and 72 h, respectively. Based on experimental transcriptomic data, we performed hierarchical modeling and determined cyclin-dependent kinase 6 (CDK6), tumor necrosis factor alpha (TNF-alpha), and transcriptional repressor CUX1 as the key regulators of the molecular response to the ATRA treatment in HL-60, NB4, and K562 cell lines, respectively. Mapping the data of TMT-based mass-spectrometric profiling on the modeling schemes, we determined CDK6 expression at the proteome level and its down-regulation at the transcriptome and proteome levels in cells treated with ATRA for 72 h. The combination of therapy with a CDK6 inhibitor (palbociclib) and ATRA (tretinoin) could be an alternative approach for the treatment of acute myeloid leukemia (AML).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteTretinoinSystems BiologyHumansHL-60 CellsGene Expression ProfilingK562 CellsDrug DiscoveryTranscriptomeCell Line, TumorCyclin-Dependent Kinase 6Antineoplastic AgentsGene Expression Regulation, LeukemicTumor Necrosis Factor-alpha

Stichwörter der Autor:innen

HL-60K562NB4acute myeloid leukemiaall-trans-retinoic acidgranulocytic differentiationproteometranscriptome

Substanzen

TretinoinCyclin-Dependent Kinase 6Antineoplastic AgentsTumor Necrosis Factor-alphaCDK6 protein, human

Autor:innen und Institutionen

  • Institute of Biomedical Chemistry, Pogodinskaya 10, 119121 Moscow, Russia.

ORCID-Profile: Svetlana Novikova, Tatiana Tolstova, Leonid Kurbatov, Tatiana Farafonova, Natalia Soloveva, Victor Zgoda

Förderung

  • Russian Science Foundation

Zitieren

APA

Novikova, S., Tolstova, T., Kurbatov, L., Farafonova, T., Tikhonova, O., Soloveva, N., Rusanov, A., & Zgoda, V. (2024). Systems Biology for Drug Target Discovery in Acute Myeloid Leukemia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25094618

Vancouver

Novikova S, Tolstova T, Kurbatov L, Farafonova T, Tikhonova O, Soloveva N, et al. Systems Biology for Drug Target Discovery in Acute Myeloid Leukemia. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25094618

BibTeX
@article{Novikova2024,
  author = {Novikova, Svetlana and Tolstova, Tatiana and Kurbatov, Leonid and Farafonova, Tatiana and Tikhonova, Olga and Soloveva, Natalia and Rusanov, Alexander and Zgoda, Victor},
  title = {Systems Biology for Drug Target Discovery in Acute Myeloid Leukemia},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25094618}
}
Kostenlos starten →